To discuss navigating the rapidly changing landscape of ER+/HER2− metastatic breast cancer (mBC), AMCP Market Insights virtually convened an expert panel of managed care stakeholders in February 2025.
JMCP Outsert - CLL (Health Plan)
Chronic lymphocytic leukemia (CLL) is a chronic lymphoproliferative disorder (lymphoid neoplasm). It is characterized by a progressive accumulation of functionally incompetent B lymphocytes, which are usually monoclonal in origin. View a patient case study and treatment plan that was discussed through the AMCP Marketing Insights Program.
For more disease state research, view the Market Insights Program.
Related
To discuss managed care approaches to bsAbs with a focus on FL and DLBCL, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in April 2025.
Read the Journal of Managed Care + Specialty Pharmacy (JMCP) - November 2025 Issue
Featured News & Resources
See Full Calendar
Other Events
Award Applications Open
Webinars
AMCP eLearning Day: Nexus Encore
National Meetings
AMCP 2026 Registration Opens
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
